Research programme: oral opioid pain therapeutics - Orexo/Uppsala
Latest Information Update: 16 Jul 2016
At a glance
- Originator Orexo; Uppsala University
- Class Opioid analgesics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Pain
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Pain in Sweden (PO)
- 30 Nov 2011 Early research in Pain in Sweden (PO)